Unique cardiac involvement in a patient with squamous cell lung cancer
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20254459Keywords:
Lung metastatis, Cardiac tumor, ST-segment elevation myocardial infarctionAbstract
Cardiac metastasis from lung tumors is rare, and often asymptomatic, making diagnosis challenging. Herein this report presents a case of a 69-year-old male with squamous cell carcinoma of the lung with cardiac metastasis to the left ventricle. Two days post chemotherapy, he developed symptoms of chest pain and mild hemoptysis. An electrocardiogram revealed ST-segment elevation in the inferior leads, suggesting a possible inferior ST-segment elevation myocardial infarction (STEMI). His symptoms improved with Nitroglycerin, and prescribed calcium channel blockers, and long-acting nitrates. The symptoms were confirmed to be attributed to an atherosclerotic plaque. This case highlights the challenge of differentiating between coronary artery disease and cardiac symptoms, and emphasizes the necessity of thorough investigation in cancer patients with cardiac symptoms.
Metrics
References
Tian L, Liu M, He L, Zhang Q, Li Q, Zhang H. Cardiac metastasis from small cell lung cancer origin: a case report and review of the literature. Cancer Rep. 2022;5(11):e1711. DOI: https://doi.org/10.1002/cnr2.1711
Lin Z, Xiao H, Liu J, Chen L, Zhang H, Huang Y, et al. Clinical features and prognosis of cardiac metastatic tumors. BMC Cancer. 2023;23(1):1235. DOI: https://doi.org/10.1186/s12885-023-11733-1
Goldberg AD, Blankstein R, Padera RF. Tumors metastatic to the heart. Circulation. 2013;128(16):1790-4. DOI: https://doi.org/10.1161/CIRCULATIONAHA.112.000790
Di Bari N, D’Errico Ramirez A, Nasso G. Primary malignant cardiac tumors: sex-related therapy and multidisciplinary approach as a new challenge for the future. J Card Surg. 2022;37(5):1287-9. DOI: https://doi.org/10.1111/jocs.16358
Coebergh JW, Janssen-Heijnen ML, Post PN, Razenberg PP. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993–1996. J Clin Epidemiol. 1999;52(12):1131-6. DOI: https://doi.org/10.1016/S0895-4356(99)00098-0
Costanzo P, Perrone-Filardi P, Petretta M, Marciano C, Vassallo E, Gargiulo P, et al. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. J Hypertens. 2009;27(6):1136-51. DOI: https://doi.org/10.1097/HJH.0b013e3283281254
Tyebally S, Ghose A, Chen DH, Abiodun AT, Ghosh AK. Chest pain in the cancer patient. Eur Cardiol. 2022;17:e15. DOI: https://doi.org/10.15420/ecr.2021.45
Zöller B, Ji J, Sundquist J, Sundquist K. Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48(1):121-8. DOI: https://doi.org/10.1016/j.ejca.2011.09.015
Yusuf SW, Daraban N, Abbasi N, Lei X, Durand JB, Daher IN. Treatment and outcomes of acute coronary syndrome in the cancer population. Clin Cardiol. 2012;35(7):443-50. DOI: https://doi.org/10.1002/clc.22007
Balanescu DV, Bloomingdale R, Donisan T, Yang EH, Parwani P, Iliescu C, et al. Mechanisms of myocardial ischemia in cancer patients: a state-of-the-art review of obstructive versus non-obstructive causes. Rev Cardiovasc Med. 2022;23(7):227. DOI: https://doi.org/10.31083/j.rcm2307227
Downloads
Published
How to Cite
Issue
Section
